Global Health Limited

As of June 30, 2026, Global Health Limited carries a market capitalization of 3.53M, placing it among publicly traded companies globally. Its enterprise value stands at 4.38M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Global Health Limited has 58.79M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.49, and the price-to-book ratio stands at -0.79.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 4.38M versus a market cap of 3.53M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Global Health Limited maintains a current ratio of 0.34, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -35.77, indicating conservative leverage, while an interest coverage ratio of -6.89 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -29.97, reflecting losses generated across the asset base.

As of the close on October 21, 2026, Global Health Limited's stock has declined approximately 40.00% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.08.

Over the twelve months ended June 30, 2026, Global Health Limited generated 7.18M in revenue and converted that into -758,220.00 in net income, yielding earnings per share of -0.01. EBITDA reached -1.39M, while operating income came in at -1.40M.

As of June 30, 2026, Global Health Limited holds 738,065.00 in cash and equivalents against 1.59M in total debt, resulting in a net debt position of 853,880.00. Total book value stands at -4.45M, with working capital of -3.85M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -19.55 and net profit margin of -10.55 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 15.28, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Global Health Limited shareholders.

Global Health Limited's most recent stock split took place on October 9, 2019 with a 24:25 split ratio.

As of June 30, 2026, Global Health Limited has an Altman Z-Score of -23.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.